Start for $99No results? No chargeSame-day approvalNo price increases — everBuy now, pay later

Medically-assisted weight loss, explained by the clinicians who prescribe it.

Dosing schedules, side effects, plateaus, and what happens after the last injection. Every article written and reviewed by Arbor’s medical team.

Woman walking confidently on a sunlit tree-lined path

150 articles, page 3 of 13

Newest first

  • Semaglutide

    Semaglutide constipation is common: in the Wegovy weight-loss trials it affected 24% of people on the medication, against 11% on placebo. Most of it responds to fiber, fluids and a routine. Here is the plan Arbor's clinicians walk patients through, and the few signs that mean you should not wait it out.

    By Arbor Health Team

  • Semaglutide

    "Ozempic face" is not a side effect listed in the Ozempic or Wegovy prescribing information. It is a nickname for the hollow, looser look that can follow fast, large weight loss, and the habits that lower the odds are the same ones Arbor's clinicians build into every GLP-1 program.

    By Arbor Health Team

  • GLP-1 Medications

    Most hair loss on a GLP-1 looks like shedding after fast weight loss, and it usually grows back. What people call Ozempic hair loss shows up in the semaglutide and tirzepatide prescribing data too, at rates of 3% to 6% in trials. Here is what causes it, what lowers your odds, and when to raise it with Arbor's clinicians.

    By Arbor Health Team

  • GLP-1 Medications

    Natural GLP-1 foods are real, but their effect is measured in minutes and percentages, not weeks. Here are 12 foods studied for GLP-1 in people, ranked by how strong the evidence is, and an honest look at why none of them works like Ozempic.

    By Arbor Health Team

  • Semaglutide

    Switching is one of the most common changes Arbor's clinicians manage, and it does not mean starting over. Here is the standard approach, what the first weeks usually feel like, and how to keep your routine steady while the new medication builds.

    By Arbor Health Team

  • Longevity

    How NAD+ supports cellular energy and healthy aging, who it is for, and what to expect from a clinician-guided program.

    By Arbor Health Team

  • Tirzepatide

    The two leading GLP-1 weight loss medications compared at the molecule level. Mechanism, clinical-trial efficacy, side effects, cost, cardiovascular outcomes, and the framework Arbor's clinical team uses to choose between them.

    By Arbor Health Team